Cambridge Capital Group

The Group have invested more than £30M in a portfolio of over 100 hi-tech startups.

Cambridge Capital Group invests in early-stage opportunities – seed, start-up and early growth.

They screen opportunities between the seed and series A stage, raising from £150,000 to £2m in S/EIS eligible equity financing. They generally refrain from investing in consumer focused businesses, unless the solution is clearly defensible, well-differentiated and operating in an attractive market.

Geographically they focus on companies based in the UK centring on The Golden Triangle of Cambridge, London and Oxford.

They actively review a wide range of hi-tech opportunities under a variety of categories including Medtech, Biotech, Agritech, Software, AI, and Life Sciences.

They provide funding for early-stage opportunities within the Seed to Series A phase, raising from £100,000 to £2m.

How it works:

-Submit your proposal via our contact form

-As we review your application, our analysts may get in touch for any additional information.

-You will be notified of how you did in the screening process.

-If successful you will be invited to participate in an upcoming CCG Pitch event.

-They hold monthly online pitching events and quarterly face-to-face pitching events.

Applicants willing to apply for the fund can do it by following this link.

Portfolio: Bango, Daniolab, Areco, Ubisense.